Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Critical Reviews in Oncology/Hematology|April 1, 2021
Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysisHedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancerJohn J W Lee, Asna Latif, Erika N Scott, et al.
Pediatric Nephrology (Berlin, Germany)|June 26, 2023
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatinHayton Chui, Kelly R McMahon, Shahrad Rod Rassekh, et al.
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
British Journal of Clinical Pharmacology|May 6, 2026
Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patientsYong Jin Lim, Amy Thachil, Kelly McMahon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Pageof 14